RETRACTED: Optimizing sgRNA to Improve CRISPR/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell
Open Access
- 19 November 2021
- journal article
- retracted article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 9
Abstract
During recent years, clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) technologies have been noticed as a rapidly evolving tool to deliver a possibility for modifying target sequence expression and function. The CRISPR/Cas9 tool is currently being used to treat a myriad of human disorders, ranging from genetic diseases and infections to cancers. Preliminary reports have shown that CRISPR technology could result in valued consequences for the treatment of Duchenne muscular dystrophy (DMD), cystic fibrosis (CF), β-thalassemia, Huntington’s diseases (HD), etc. Nonetheless, high rates of off-target effects may hinder its application in clinics. Thereby, recent studies have focused on the finding of the novel strategies to ameliorate these off-target effects and thereby lead to a high rate of fidelity and accuracy in human, animals, prokaryotes, and also plants. Meanwhile, there is clear evidence indicating that the design of the specific sgRNA with high efficiency is of paramount importance. Correspondingly, elucidation of the principal parameters that contributed to determining the sgRNA efficiencies is a prerequisite. Herein, we will deliver an overview regarding the therapeutic application of CRISPR technology to treat human disorders. More importantly, we will discuss the potent influential parameters (e.g., sgRNA structure and feature) implicated in affecting the sgRNA efficacy in CRISPR/Cas9 technology, with special concentration on human and animal studies.Keywords
This publication has 211 references indexed in Scilit:
- Efficient genome editing in plants using a CRISPR/Cas systemCell Research, 2013
- Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidisProceedings of the National Academy of Sciences, 2013
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- In vivo genome editing using a high-efficiency TALEN systemNature, 2012
- The rice ERF transcription factor OsERF922 negatively regulates resistance to Magnaporthe oryzae and salt toleranceJournal of Experimental Botany, 2012
- Evolution and classification of the CRISPR–Cas systemsNature Reviews Microbiology, 2011
- Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilusJournal of Bacteriology, 2008
- Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design toolNucleic Acids Research, 2007
- CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studiesMicrobiology, 2005
- GENETIC DISEASES AND GENE KNOCKOUTS REVEAL DIVERSE CONNEXIN FUNCTIONSAnnual Review of Physiology, 1999